RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vitaspring Biomedical Co. Stock

Vitaspring Biomedical Co. ROCE 2024

Vitaspring Biomedical Co. ROCE

0.94

Ticker

VSBC

ISIN

US92851B1026

In 2024, Vitaspring Biomedical Co.'s return on capital employed (ROCE) was 0.94, a -121.92% increase from the -4.3 ROCE in the previous year.

Vitaspring Biomedical Co. Aktienanalyse

What does Vitaspring Biomedical Co. do?

Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Vitaspring Biomedical Co.'s Return on Capital Employed (ROCE)

Vitaspring Biomedical Co.'s Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Vitaspring Biomedical Co.'s ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Vitaspring Biomedical Co.'s ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Vitaspring Biomedical Co.’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Vitaspring Biomedical Co. stock

What is the ROCE (Return on Capital Employed) of Vitaspring Biomedical Co. this year?

The ROCE of Vitaspring Biomedical Co. is 0.94 undefined this year.

How has the ROCE (Return on Capital Employed) of Vitaspring Biomedical Co. developed compared to the previous year?

The ROCE of Vitaspring Biomedical Co. has increased by -121.92% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Vitaspring Biomedical Co.?

A high Return on Capital Employed (ROCE) indicates that Vitaspring Biomedical Co. has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Vitaspring Biomedical Co.?

A low ROCE (Return on Capital Employed) can indicate that Vitaspring Biomedical Co. has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Vitaspring Biomedical Co. impact the company?

An increase in the ROCE of Vitaspring Biomedical Co. can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Vitaspring Biomedical Co. affect the company?

A decrease in ROCE of Vitaspring Biomedical Co. can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Vitaspring Biomedical Co.?

Some factors that can affect Vitaspring Biomedical Co.'s ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Vitaspring Biomedical Co. so important for investors?

The ROCE of Vitaspring Biomedical Co. is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Vitaspring Biomedical Co. take to improve the ROCE?

To improve the ROCE, Vitaspring Biomedical Co. can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Vitaspring Biomedical Co. pay?

Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of Vitaspring Biomedical Co.?

The current dividend yield of Vitaspring Biomedical Co. is .

When does Vitaspring Biomedical Co. pay dividends?

Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vitaspring Biomedical Co.?

Vitaspring Biomedical Co. paid dividends every year for the past 0 years.

What is the dividend of Vitaspring Biomedical Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vitaspring Biomedical Co. located?

Vitaspring Biomedical Co. is assigned to the '-' sector.

Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vitaspring Biomedical Co. from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Vitaspring Biomedical Co. pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Vitaspring Biomedical Co. in the year 2023?

In the year 2023, Vitaspring Biomedical Co. distributed 0 USD as dividends.

In which currency does Vitaspring Biomedical Co. pay out the dividend?

The dividends of Vitaspring Biomedical Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vitaspring Biomedical Co.

Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.